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ABSTRACT 
Complementary and alternative medicine (CAM) is becoming increasingly popular and experienced a high 
growth all over the world. A medicinal plant, Swertia chirata, has been widely use as herbal medicine in 
Asian countries and some parts of the world. The aim of this study was to evaluate the antibacterial 
properties of Swertia chirata and to assess the cytotoxicity using brine shrimp lethality test. Plants were 
extracted using ethanol. Disc diffusion technique was used to determine antimicrobial activity. Crude 
extraction of the whole plant showed significant antimicrobial activities against some clinical bacterial 
isolates. Plant extracts at a concentration of 100 μg disc-1 were used to evaluate the antimicrobial activity 
and 30 μg disc-1 concentration of Chloramphenicol was used as a positive control. Zone of inhibition against 
Staphylococcus aureus, Bacillus cereus, Escherichia coli and Salmonella arizonae were 10 mm, 6 mm, 9 mm 
and 7 mm respectively. Minimum Inhibitory Concentration (MIC) of the crude extract was determined by 
serial dilution technique which showed 128 µg/ml, 64 µg/ml, 128 µg/ml and 128 µg/ml respectively. Plant 
showed no significant cytotoxitcity with LC50 >5000 µg.The results obtained revealed inhibition against some 
gram positive and gram negative bacteria and low cytotoxicity value indicates its effective use as traditional 
medicine plant. Thus, Swertia chirata which possesses antimicrobial activity, with low cytotoxicity, will be of 
use in complementing a standard antimicrobial drug and will contribute to the current status of the public 
health where emergence of drug resistance is a major problem. 
Keywords: Swertia chirata; antibacterial, complementary and alternative Medicine (CAM), minimum 
inhibitory concentration (MIC), LC50 
 
 
INTRODUCTION 
Traditional systems of medicine are fast emerging as an alternative to modern medical and health science. 
In recent years the emphasis on herbal plants as a source for drug discovery and development has been 
realized globally. The concept of scientific validation of the basis of traditional uses of herbal medicines 
has given birth to a new concept of reverse pharmacology, and interactions between traditional and 
modern systems of medicine are being increasingly encouraged. Recent Trends in Herbal Drug Research 
and Therapy showcases some of these crucial and emerging issues relating to herbal drugs (Arunabha et 
al., 2010). The use of higher plants and preparations made from them to treat infections is an old-age 
practice in a large part of the world population, especially in developing countries, where there is 
dependence on traditional medicine for variety of diseases (Ahmad et al., 1998, Alam et al., 2009). The 
economic crisis, high cost of industrialized medicines, inefficient public access to medicinal and 
pharmaceutical care, in addition to the side effects caused by synthetic drugs are of some of the factors 
contributing to the central role of medicinal plants in health care (Johann et al., 2007, Alam et al., 2009)  
Swertia chirata, is a robust annual herb which grows up to about 1.5 meters in height. It has leaves in 
opposite pair about 10 cms long, without stalks, pointed at the tip. The plant has numerous flowers, pale 
green in colour, tinged with purple, with long white or pink hairs and minute sharp pointed fruits. The 
whole plant, collected in its flowering stage and dried, constitutes the drug. It is found in the Himalayan 
ranges of India from Kashmir to Bhutan at an altitude of 1,200-3,000 m. It is also found in the Khasi Hills of 
Meghalaya at an altitude of 1,200-1,500 m. (Joshi & Dhawan 2005, Anwar et al., 2011). It has long been 
used by the ayurvedic physicians as a bitter tonic. The plant contains a bitter glycoside chiratin, which 
yields on hydrolysis, two bitter principle, ophelic acid and chiratin. The ophelic acid is a brown hydroscopic 
substance which is soluble in water and alcohol. It also contains resin, tannin and 4 to 8 per cent of ash 
(Joshi & Dhawan 2005). Chirata is an effective drug for reducing fevers (Sampath Kumar et al., 2010). It has 
been widely use as herbal medicine in Asian countries particularly in India, Nepal, Myanmar, Arab and 
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some parts of the European countries. Reported studies showed extracts of this plant has attributable 
properties as hypoglycemic, antipyretic (Bhargava et al., 2009), anti-inflammatory (Banerjee et al., 2000), 
antibacterial (Ali et al.2009), antiviral (Verma et al), antimalarial, antihepatotoxic (Joshi & Dhawan 2005) 
and wound healing activity (Rafatullah et al., 1993). In 2009, it was announced in Annual Professional 
Conference of Diabetes UK, proven to have an anti-diabetic effect (Health News 2011). In this study, 
ethanolic extract of different fractions of Swertia chirata was evaluated to assess its antimicrobial property 
and brine shrimp lethality test was done to evaluate the cytotoxicity of the plant. 
 
MATERIAL AND METHODS 
Identification of samples 
Dried plants of S. chirata were obtained from registered traditional herbal medicine center, Myanmar. 
Locally known as Seykhagyi, identification and confirmation was performed by licensed traditional herbal 
medicine expert. 
 
Preparation of plant materials 
Parts of the plants were separated into stem and leaves and cut into smaller pieces and placed in an 
autoclave at 400C 24 hours for further drying. Then it was weighed about 100g for each stem and leaves and 
ground into coarse powder with grinding machine at the Institute of Medical Molecular Biotechnology 
(IMMB), Sungai Buloh, Malaysia.  
 
Extraction, evaporation and isolation of compounds 
100 g of plant samples were taken to dissolved with 80% ethanol in a 500 ml conical flask and placed on a 
shaker for 7 days. It was decanted and filtered using fresh cotton wool. This procedure was repeated three 
times to the same filtrate to achieve as much active compounds as possible. Thus, total of 1500 ml of filtrates 
was lastly obtained in a beaker. The solvent was then placed in rotatory evaporator until semisolid gummy 
mass was obtained. It was then preserved at 40C until further analysis. 100 mg of crude extract of leaf and 
stem powder of S. chirata were then dissolved in 10 ml of 80% ethanol and ready to be tested with different 
microbial agents.  
 
Tested microbial agents 
Pure cultures of Staphylococcus aureus and Bacillus cereus for gram positive bacteria, Escherichia coli and 
Salmonella arizonae for gram negative bacteria were used as the experimental microorganisms isolated from 
Center for Pathology & Diagnostic Research Laboratories (CPDRL), Universiti Teknologi MARA, Sungai 
Buloh, Malaysia.  
 
Antimicrobial study 
Disc diffusion method was performed according to Clinical and Laboratory Standards Institute guidelines 
(CLSI, 2012) and Minimal Inhibitory Concentration (MIC) was carried out using the reference broth 
microdilution method as described by the National Committee for Clinical Laboratory Standards. Standard 
Chloramphenicol disc (30µg disc-1) was use as a positive control. Test materials impregnated with respective 
solvents (different strength 100%, 75%, 50% & 25%) were soaked into 100µg disc-1 (Whatman filter paper 
disc) and antimicrobial potency was measured. 
  
Cytotoxicity bioassay 
100mg of crude extract of leaf and stem powder of S. chirata were then dissolved in 10ml of 80% ethanol and 
ready to be tested for the brine shrimp bioassay test. Commercially available cysts of brine shrimps were 
obtained from Ocean star international (O.S.I.) Inc. made in U.S.A. Artificial seawater (ASW) was used as 
culture medium. Two unequal compartments were used; one darkened and smaller one was illuminated with 
lump (250C) and was connected with small holes. Brine shrimp eggs were placed in larger compartment 
filled with artificial seawater (ASW). After 48 h the eggs were hatched and phototropic nauplii were collected 
by pipette from the lighted side which had passed through the small holes from the darker compartment. 
Bioassay was done with the vials to which a drop of dimetyl sulfoxide (DMSO) solvent was added. Then, ten 
nauplii were placed using Pasteur pipette, and 4.5 ml ASW was added. To this vials 0.5ml of plant extract 
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was added with total volume of 5ml and maintained at room temperature. Different concentration of plant 
extract was used to detect LC50 (concentration of 50% mortality of the nauplii). After 24 hours, nauplii were 
counted against a lighted background. Experiments were conducted along with podophyllotoxin as positive 
control and different concentrations (1-5000 µg/ml) of the test substances. 
 
RESULTS AND DISCUSSION 
The study showed that different fraction of both leaves and stems showed antimicrobial property against 
some gram positive and gram negative microorganisms. Zone of inhibition against S. aureus, B. cereus, E. 
coli and S. arizonae were 10mm, 6 mm, 9 mm and 7 mm respectively. Results were summarized in Table I 
and Table II. 
 
Table I: Antibacterial activity of the crude extract of S. chirata leaf 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table II: Antibacterial activity of the crude extract of S. chirata stem 
 
 
 
 
 
 
 
 
 
 
 
 
*Values indicate zone of inhibition (diameter in mm) 
 
Antibacterial property of ethanolic crude extract of both S. chirata leaves and stem showed both possessed 
inhibition against test organisms without much difference in inhibition zones. For gram positive bacteria, 
zone of inhibition for S. aureus was 10 mm and 9 mm whereas for B. cereus 6 mm and 6 mm respectively. 
For gram negative bacteria, E.coli showed inhibition zone of 9 mm and 9 mm and S. arizonae showed 7 mm 
and 7 mm respectively for full strength. In concentration of 75%, only S. aureus and E.coli showed inhibition 
zone a little less than full strength, others revealed no significant inhibition. The results support previous 
studies (Jesmin et al., 2007, Alam et al., 2009) and showed that antimicrobial activity was best at full 
concentration. 
 
Minimum inhibitory concentration (MIC) of the test sample 
Minimum Inhibitory Concentration (MIC) of ethanolic crude extract mixture (stem and leaves) was 
determined by serial dilution technique, which showed 128 µg/ml, 64 µg/ml, 128 µg/ml and 128 µg/ml for S. 
aureus, B. cereus, E.coli and S. arizonae respectively. Results for S. aureus, B. cereus differ from results 
Tested Microbial agents 
 
Concentrations of tested crude extracts of S. chrata 
(µg disc-1) 
Standard 
Chloramphenicol  
disc (30µg disc-1) 
100% 
 
75% 
 
50% 
 
25% 
 
Staphylococcus aureus 10* 6 - - 33 
Bacillus cereus 
 
6 - - - 33 
Escherichia coli 
 
9 4 - - 34 
Salmonella arizonae 
 
7 - - - 33 
Tested Microbial agents 
 
Concentrations of tested crude extracts of S. chrata 
(µg disc-1) 
Standard 
Chloremphenicol disc 
(30µg disc-1) 
100% 75% 50% 25% 
Staphylococcus aureus 9* 7 - - 33 
Bacillus cereus 
 
6 - - - 33 
Escherichia coli 
 
9 4 - - 34 
Salmonella arizonae 
 
7 - - - 33 
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obtained  by Sultana et al., which showed 64 µg/ml for S.aureus and  128 µg/ml for B. cereus whereas for 
gram negative bacteria showed no significant difference. Results were summarized in Table III.  
 
Table III: Minimum Inhibitory Concentration (μg/ml) values of ethanolic extract of S. chirata 
 
 
 
 
 
 
 
 
 
 
 
 
Cytotoxicity bioassay 
The brine shrimp lethality assay is an easy, rapid, inexpensive bioassay for testing plant extracts bioactivity 
properties of the plants (Alluri et al., 2006). In this study, the LC50 value of S. chirata extracts were 
determined using brine shrimp lethality assay which showed  >5000 µg. This result showed no significant 
effect compared with  the control.The results obtained in this study is in consistant with the experiment 
done by Alluri et al.,but did not support the study done by Sultana et al., which was 60.25 µg that indicates 
high cytotoxic effect of the plant. 
 
CONCLUSION 
The ethanolic extract of the medicinal plant S. chirata both stem and leaves demonstrate appreciable 
antibacterial property. From the preliminary testing, this plant has no significant cytotoxic effect with LC50 
of >5000mg which support the safe traditional use as medicinal plant (Alam et al., 2009). Although the 
results obtained revealed inhibition against some gram positive and gram negative bacteria, further study 
need to be carried out to detect the active compounds of this highly potent plant. Further work will be 
continued for the identification of the isolated pure compound as well as its biological activity against 
medically important microorganisms. Hence, S. chirata, a herbal medicine with potent antimicrobial 
activity, will not only complement a standard antimicrobial drug but will solve the issues of high cost of 
industrialized medicines and will contribute to CAM especially in developing countries where there is 
difficulty in public access to medicinal and pharmaceutical care. 
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